1035 CD26+ CD4+ T cells impart enhanced anti-tumor immunity and improved prognosis in early-stage breast cancer patients | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Regular and Young Investigator Award Abstracts

Immune Cell Types and Biology

1035 CD26+ CD4+ T cells impart enhanced anti-tumor immunity and improved prognosis in early-stage breast cancer patients

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

	Abstract	Full	Pdf
Nov 2023	116	0	5
Dec 2023	38	0	9
Jan 2024	33	0	4
Feb 2024	28	0	3
Mar 2024	20	0	7
Apr 2024	18	0	6
May 2024	22	0	5
Jun 2024	14	0	0
Jul 2024	18	0	3
Aug 2024	14	0	3
Sep 2024	14	0	4
Oct 2024	18	0	5
Nov 2024	20	0	6
Dec 2024	56	0	3
Jan 2025	10	0	5
Feb 2025	0	0	6
Mar 2025	0	0	8
Apr 2025	1	0	5
May 2025	0	0	7
Jun 2025	0	0	3
Total	440	0	97